AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 MAY 6 - (NewsRx.com & NewsRx.net) -- Researchers believe the increased risk of invasive breast cancer as reported in the Million Women Study (MWS) was was not justifiable.
"MWS published in the summer of 2003, has suggested unexpected high risks for invasive breast cancer in women using postmenopausal hormone therapy (PHT)," scientists in Netherlands report.
"Recent reports from randomized controlled trials (RCTs) have demonstrated that long-term combined PHT is associated with a small risk increase for invasive breast cancer, but not for death due to breast cancer," wrote M.J. van der Mooren and colleagues, Free University of Amsterdam, Medical Center.
"The observational design of the MWS has made this study subject to several biases that can easily explain the discrepancy with the observations done in RCTs and several other lane observational studies. It is concluded that the hormone fear that was caused by the MWS, and augmented by some professionals and the media, ...